Evidence map›Paper›PMID 39917984›Full record

ArticleMolecular imaging and radionuclide therapy2025

Improved Accuracy and Reliability of PRIMARY Scoring Using Delayed [

Kaan Akçay, Gamze Beydağı, Onur Erdem Şahin, Reşit Akyel, Elife Akgün, Özgül Ekmekçioğlu, Nalan Alan Selçuk, Türkay Toklu, Asiye Işın Doğan Ekici, Kayra Kapran and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07168616 (Prospective Evaluation of Istanbul PSMA PET/CT Criteria for Selecting Candidates for Active Surveillance in Low-Risk Prostate Cancer), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07168616 recruitingnot on this map

Prospective Evaluation of Istanbul PSMA PET/CT Criteria for Selecting Candidates for Active Surveillance in Low-Risk Prostate Cancer

Typeobservational_patient_registrySponsorIstanbul University - CerrahpasaRan2025 to 2028Enrolled201ConditionsLow Risk Prostate Cancer, Clinically Significant Prostate CancerArmsGa-68 PSMA11 PET/CT
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kaan AkçayYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-7706-6388
Gamze BeydağıYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0001-7187-7203
Onur Erdem Şahinİstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0003-2330-8078
Reşit AkyelYedikule Chest Diseases and Chest Surgery Training and Research Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0001-9373-8693
Elife AkgünUniversity of Health Sciences Türkiye, Başakşehir Çam and Sakura City Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0001-5625-9749
Özgül EkmekçioğluUniversity of Health Sciences Türkiye, Şişli Hamidiye Etfal Training and Research Hospital, Clinic of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-3313-8087
Nalan Alan SelçukYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-3738-6491
Türkay TokluYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-5399-9394
Asiye Işın Doğan EkiciAcıbadem University Faculty of Medicine, Department of Pathology, İstanbul, Türkiye.ORCID 0000-0003-4062-9519
Kayra KapranYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0009-0002-3693-1512
Levent KabasakalYeditepe University Faculty of Medicine, Department of Nuclear Medicine, İstanbul, Türkiye.ORCID 0000-0002-4050-1972

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Delayed [ Methods: A total of 140 patients with biopsy results of International Society of Urological Pathology grade groups (ISUP) 1-2 who had standard (median 60 min) and delayed images (median 138 min) with [ Results: The percentage of lesions scored as 1-2 in PRIMARY scoring decreased from 29% to 10% in delayed images compared with standard images, whereas lesions scored as 3-5 increased from 71% to 90%. Additionally, agreement between two experienced nuclear medicine physicians regarding scoring was 66% for standard imaging and 77% for delayed imaging. The number of patients with PRIMARY score 5 increased from 31 to 46 in delayed imaging. All patients were confirmed to have clinically significant prostate cancer (csPCa). Furthermore, no csPCa of ISUP grade 3 or higher was detected in patients with a delayed PRIMARY score (dPRIMARY). The sensitivity of standard PRIMARY scoring was 71%, which increased to 92% with dPRIMARY scoring, with a consistent positive predictive value of 87% for both. Intraobserver agreement Cohen's kappa values for all observers were higher for delayed images than for standard images. Inter-observer agreement, assessed by Fleiss kappa, was 0.47 and 0.52 for standard images in rounds 1 and 2, respectively, and 0.61 and 0.72 for delayed images, respectively. Conclusion: Decreased background activity and increased primary tumor uptake in delayed images improved differentiation between primary tumors and benign lesions, leading to better primary tumor identification. Enhanced reliability was also observed in both intraobserver and interobserver assessments of delayed images.

Indexed as

active surveillanceclinically significant prostate cancerprimary stagingprostate biopsyprostate cancerProstate-specific membrane antigen

Identifiers

PMID39917984
PMCPMC11827525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.